TY  - GEN
AU  - Ladetto,M
AU  - Zallio,F
AU  - Vallet,S
AU  - Ricca,I
AU  - Cuttica,A
AU  - Caracciolo,D
AU  - Corradini,P
AU  - Astolfi,M
AU  - Sametti,S
AU  - Volpato,F
AU  - Bondesan,P
AU  - Vitolo,U
AU  - Boccadoro,M
AU  - Pileri,A
AU  - Gianni,A M
AU  - Tarella,C
TI  - Concurrent administration of high-dose chemotherapy and rituximab is a feasible and effective chemo/immunotherapy for patients with high-risk non-Hodgkin's lymphoma
SN  - 0887-6924
PY  - 2002///0122
KW  - Adult
KW  - Antibodies, Monoclonal
KW  - administration & dosage
KW  - Antibodies, Monoclonal, Murine-Derived
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - Drug Administration Schedule
KW  - Feasibility Studies
KW  - Female
KW  - Hematopoietic Stem Cell Transplantation
KW  - Humans
KW  - Immunotherapy
KW  - Lymphoma, Non-Hodgkin
KW  - complications
KW  - Male
KW  - Middle Aged
KW  - Neoplasm, Residual
KW  - diagnosis
KW  - Polymerase Chain Reaction
KW  - Rituximab
KW  - Salvage Therapy
KW  - Transplantation, Autologous
KW  - Treatment Outcome
N1  - Publication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1038/sj.leu.2402302
ER  -